Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study (Q43841710)

27 November 2017

title

Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study (English)

1 reference

27 November 2017

0 references

1 reference

Spahn JD

1

1 reference

27 November 2017

Fost DA

2

1 reference

27 November 2017

Covar R

3

1 reference

27 November 2017

Martin RJ

4

1 reference

27 November 2017

Brown EE

5

1 reference

27 November 2017

Szefler SJ

6

1 reference

27 November 2017

Leung DY

7

1 reference

27 November 2017

publication date

1 December 2001

1 reference

Annals of Allergy, Asthma & Immunology

27 November 2017

published in

1 reference

27 November 2017

volume

87

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

501-505

1 reference

The use of macrolide antibiotic substances in the treatment of asthma

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Enhancement by oleandomycin of the inhibitory effect of methylprednisolone on phytohemagglutinin-stimulated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Steroid-resistant asthma: immunologic and pharmacologic features

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Antiasthmatic activity of a macrolide antibiotic, roxithromycin: analysis of possible mechanisms in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Molecular pathology of allergic disease: I: lower airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Mechanisms of eosinophil-associated inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Steroid Resistance in Bronchial Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Effect of clarithromycin and azithromycin on production of cytokines by human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962264-8

7 January 2021

10.1016/S1081-1206(10)62264-8

Identifiers

DOI

1 reference

27 November 2017

1 reference